Company Filing History:
2 out of 71 
1 out of 1,745 
1 out of 60 
Years Active: 2022-2025
Title: Bernard Mlecnik: Innovator in Cancer Prognosis
Introduction
Bernard Mlecnik is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer research, particularly in developing methods for predicting patient outcomes.
Latest Patents
Mlecnik holds 2 patents related to innovative methods for predicting the survival time and treatment responsiveness of patients suffering from solid cancers. His patented methods involve determining gene expression levels in tumor samples and comparing them to predetermined reference values. This approach allows for a prognosis that can be categorized as good, bad, or intermediate based on the expression levels of at least seven specific genes.
Career Highlights
Throughout his career, Mlecnik has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université de Paris. His work has been pivotal in advancing the understanding of cancer prognosis and treatment responsiveness.
Collaborations
Mlecnik has collaborated with notable colleagues in the field, including Jerome Galon and Franck Pages. Their combined expertise has contributed to the development of innovative cancer research methodologies.
Conclusion
Bernard Mlecnik's work exemplifies the intersection of innovation and medical research, particularly in the realm of cancer prognosis. His contributions continue to impact the field significantly.